Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTE9)Product type:GuidanceProgramme:Health technology evaluationLast updated: 14 December 2023Published: 16 May 2023
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment (HTE15)Product type:GuidanceProgramme:Health technology evaluationPublished: 15 November 2023
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment (HTE3)Product type:GuidanceProgramme:Health technology evaluationLast updated: 5 September 2023Published: 8 February 2023
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults (IPG693)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 April 2021
Alpha-Stim AID for anxiety disorders (MTG56)Product type:GuidanceProgramme:Medical technologies guidancePublished: 8 March 2021
Transcranial magnetic stimulation for obsessive-compulsive disorder (IPG676)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 5 August 2020
Generalised anxiety disorder and panic disorder in adults: management (CG113)Product type:GuidanceProgramme:Clinical guidelineLast updated: 15 June 2020Published: 26 January 2011
Post-traumatic stress disorder (NG116)Product type:GuidanceProgramme:NICE guidelinePublished: 5 December 2018
Social anxiety disorder: recognition, assessment and treatment (CG159)Product type:GuidanceProgramme:Clinical guidelinePublished: 22 May 2013
Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31)Product type:GuidanceProgramme:Clinical guidelinePublished: 29 November 2005